Drugs / CD133
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01120925 | May 2010 → Jul 2013 | cirrhosis of liver | Royan Institute | Completed | No outcome recorded |
| Phase 1/2 | NCT00713934 | Jan 2008 → Jan 2009 | cirrhosis of liver, disease related to hematopoietic stem cell transplant | Royan Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD133 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01120925 ↗ |
| Route | Other | “portal vein infusion of CD133+ cells” NCT00713934 ↗ |